For patients with demyelinating disease, as indicated by imaging results, CSF should be examined for anti-aquaporin-4 antibody, anti-myelin oligodendrocyte glycoprotein antibody, anti-myelin basic protein antibody, and oligoclonal bands to further clarify the diagnosis. This evidence concerns the gene AQP4 and demyelinating disease.